ENHERTU® Demonstrated Clinically Meaningful and Durable Responses in Patients Across Multiple HER2 Expressing Advanced Solid Tumors
Daiichi Sankyo and AstraZeneca’s ENHERTU showed an objective response rate of 37.1% in the overall…
Daiichi Sankyo and AstraZeneca’s ENHERTU showed an objective response rate of 37.1% in the overall…
Leading Global Provider of Pharmaceutical and Medical Solutions to the Maritime Industry Establishes Distribution Center…
Industry veteran and senior medical leader from Pfizer brings deep global expertise as Vaxxas advances…
Encouraging interim results from Phase 1 human clinical trial show COVID-19 vaccine candidate, called HexaPro,…
SEOUL, South Korea--(BUSINESS WIRE)--#BIOInternationalConvention--Basgenbio Inc., a clinico-genomic cohort data-based R&D company, has announced that the…
Basic engineering of Vast’s 30MW VS1 Port Augusta CSP Project to be completed by July…
Tocilizumab is an important anti-rheumatic agent used in the treatment of adult patients with moderate…
New list highlights companies recognized globally for employee sentiment and satisfaction SPARTANBURG, S.C.--(BUSINESS WIRE)--Milliken &…
- Novel seed treatment brings next-level sustainability in pest control while promoting healthy plant establishment…
SHANGHAI--(BUSINESS WIRE)--AntChain announced a new collaboration with Intel to launch AntChain Massive Data Privacy-Preserving Computing…